Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.

Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE Jr, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS.

J Virol. 2016 Apr 29;90(10):5090-5097. doi: 10.1128/JVI.00155-16. Print 2016 May 15.

2.

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers.

Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE Jr, Lok SM.

Science. 2015 Jul 3;349(6243):88-91. doi: 10.1126/science.aaa8651.

3.

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.

Fibriansah G, Tan JL, Smith SA, de Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang J, Harris E, de Silva A, Crowe JE Jr, Lok SM.

EMBO Mol Med. 2014 Mar;6(3):358-71. doi: 10.1002/emmm.201303404. Epub 2014 Jan 13.

4.

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr.

MBio. 2013 Nov 19;4(6):e00873-13. doi: 10.1128/mBio.00873-13.

5.

Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.

Ibarra KD, Jain MK, Pfeiffer JK.

J Virol. 2011 Jul;85(14):7273-83. doi: 10.1128/JVI.00629-11. Epub 2011 May 4.

6.

Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.

Ibarra KD, Pfeiffer JK.

J Virol. 2009 May;83(9):4538-47. doi: 10.1128/JVI.02280-08. Epub 2009 Feb 25.

Supplemental Content

Loading ...
Support Center